Seasonality Snapshot

Moderna (MRNA)

mRNA Biotech · US · US Healthcare & Biotech
✓ VERIFIED · 9YR REAL DATA
JanFebMarAprMayJunJulAugSepOctNovDec
SEASONAL HEADWIND — August
Strongest Month
January
+11.23% avg · 63% win rate
Weakest Month
August
-6.53% avg · 38% win rate
MonthAvg ReturnWin Rate
January +11.23% 63%
February +1.61% 38%
March +1.86% 50%
April +9.65% 63%
May +5.78% 63%
June +3.86% 50%
July +6.61% 63%
August NOW -6.53% 38%
September -1.90% 57%
October -3.22% 43%
November +2.97% 67%
December -3.33% 43%
These figures are computed from 9 years of actual monthly closing prices. Past seasonal patterns are not a guarantee of future performance. See our methodology for how this is calculated, or visit the Academy to learn how to read seasonal data responsibly.

Moderna seasonality — common questions

What is Moderna's best month historically?
Historically, January has been Moderna's strongest month, averaging +11.23% with a 63% win rate over 9 years of data. August has been the weakest at -6.53%.
Is Moderna seasonal?
Moderna shows a measurable seasonal pattern: its best and worst months differ by 17.76 percentage points on average. These figures come from 9 years of real monthly closing prices. Seasonality is a historical tendency, not a prediction.
How does Moderna historically perform in August?
Moderna is currently in August, which has historically averaged -6.53% with a 38% win rate. That has historically been a seasonally weak window.

Get the full analysis

Backtest this seasonal pattern, compare it against other assets, set alerts, and explore detrended & presidential-cycle views.

Open the Analyzer →
TimingAX is an independently operated service, not a registered investment adviser. This page is for informational purposes only and is not financial advice.